Navigation Links
Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
Date:9/25/2008

eases including breast and uterine cancers, heart disease, stroke and blood clots," said Dr. Tagliaferri. "Independent studies have shown that the major reason postmenopausal women refrain from sexual activity is due to vaginal dryness. Considering the lack of safe treatment options for this indication, and given the data we have developed on this drug candidate, VG101 could be a superior treatment for the millions of women who want to improve both their quality of life as well as sexual functioning."

The North American Menopause Society (NAMS) is the leading nonprofit organization dedicated to promoting the health and quality of life of menopausal women. NAMS has a multidisciplinary membership of over 2,000 leaders in the field of women's health.

About VG101

VG101 is an intravaginal drug designed for the treatment of vaginal atrophy and dryness in menopausal women. VG101 is a novel estrogen receptor beta selective agonist and unlike currently available hormone therapies, does not activate the estrogen receptor alpha, which is known to be implicated in both breast and uterine tumor formation. Phase 1/2 clinical testing of VG101, under the directorship of Dr. Deborah Grady, will commence within the next year.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more inf
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... PLAINFIELD, N.J. , May 16, 2013  PTC ... registration statement on Form S-1 with the U.S. Securities ... public offering of its common stock. The number of ... the offering have not been determined. (Logo:  ... Credit Suisse are acting as joint book-running managers for ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
(Date:5/16/2013)... May 16, 2013  Alere Inc. (NYSE: ALR ... of their health at home through the merger of rapid ... $3.00 per share on its Series B Convertible Perpetual Preferred ... 2013 to holders of record of Series B stock at ... Such payment will cover the amount of all dividends accrued ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Calif., Dec. 12 BioForm Medical,Inc. (Nasdaq: ... multi-center,randomized, blinded comparative study of nasolabial fold treatments,reporting ... reported after treatment with either Juvederm(TM) or Perlane(R). ... December 2007 Filler Issue of,the Journal of Dermatologic ...
... Solvay Pharmaceuticals, Inc.,announced today that the company ... and Drug Administration (FDA) to fully address the ... in its meeting to,consider tedisamil as a treatment ... normal sinus rhythm (NSR)., The Committee voted ...
Cached Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation 2
(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s ... is all about is getting results in the fastest amount ... ’s Stan Stevenson, prompting an investigative review. , “ ... system” designed to make you faster, stronger, fitter and trimmer ... in the gym. The training manual and exercise video database ...
(Date:5/18/2013)... Morro Bay, CA (PRWEB) May 18, 2013 ... salon , has recently completed a stylish renovation that ... and advanced specialties. , From the ground up, this ... been improved with fresh flooring, soothing colors and comfortable ... have been installed, including an Apilus epilator machine. ...
(Date:5/18/2013)... 18, 2013 Dr. Robert Tracey, an area ... employs his knowledge of the root causes of sleep ... With May being Better Sleep Month, Dr. Tracey points out ... chronic sleep disorder, and sleep apnea is one of the ... person will essentially stop breathing at different times while sleeping. ...
(Date:5/18/2013)... May 18, 2013 The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... PDUs) for attending them. , These trainings are suitable for ... also ideal for those who will be a part of ... who want to explore Agile and Scrum, but are unsure ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3
... believe a brain imaging approach that combines standard ... techniques could lead to more effective diagnoses in ... the brain. ,James Leach, MD, reports ... American Journal of Neuroradiology. This is the first ...
... mutations of the gene responsible for the debilitating ... study claims to make treatment more specific for ethnic groups ... by genetic tests. , Says Irwin McLean ... University of Dundee, who led the study:” Once we cracked ...
... are describing as a “ U-turn of dramatic proportions”, a ... can in fact prevent// them from the risks of heart ... of the American Medical Association shows that hormone replacement therapy ... put such women at higher risks of heart attacks and ...
... least 2,500 years old. It claims to be the world's oldest inhabited ... ,Its population of 1.74 millions is said to be living ... is a scarce commodity, whatever water is available is soaked up by ... with cheeks bulging bizarrely as they get their fix. It is a ...
... be worth over $200 million and is expected to grow to ... ,The growth of the food industry is also going ... industry, which is currently growing at nine percent. ,These ... food meet to be held in New Delhi April 10-11, which ...
... even faster than the climate around it since the late ... of 2040//, according to a study by professors at ... largest freshwater lake in the world by surface area. ... increased about 4.5 degrees since 1979, compared with about a ...
Cached Medicine News:Health News:Combined Imaging Approach may Be Effective in Diagnosing Some Brain Clots 2Health News:More Mutations Of Gene That Cause Skin Disorders And Asthma Discovered 2Health News:Hormone Replacement Therapy- Not A Fallen Angel 2Health News:Drug Uses Up Water in Yemeni Capital, People Must Relocate 2
Table mount stabilizer system...
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy....
... Nd:YAG laser system with a wavelength of 1,064 ... superficial as well as red and blue vein ... patients with darker skin types (1 to 6) ... general improvement of skin texture. The handpieces special ...
... SINON is a Q-switched ... wavelength of 694 nm. High ... Pulses - This combination of ... pulses in Q-switched mode effectively ...
Medicine Products: